Seeking Alpha

Beacon VP Investments

 
(In beta) Send Us Feedback»
Title Symbol Long/
Short
Date of
publication
3m from
publication
6m from
publication
1y from
publication
Antares' Otrexup Ready For FDA Approval ATRS Long
10/10/2013
12.0%
-26.7%
-56.8%
Anacor's Drug Tavaborole Should Receive FDA Approval ANAC Long
8/16/2013
29.8%
81.6%
92.3%
Keryx Biopharmaceuticals' Zerenex Likely To Receive FDA Approval KERX Long
7/22/2013
28.3%
70.6%
66.0%
Theravance's Drug Breo Likely To Receive FDA Approval THRX Long
3/4/2013
41.8%
48.4%
46.7%
Depomed's Drug Serada Ready For FDA Approval DEPO Long
2/20/2013
-16.5%
2.1%
90.7%
MAP's Levadex Ready For FDA Approval MAPP Long
2/3/2013
-
-
-
Alexza's Adasuve May Not Be Ready For FDA Approval ALXA Short
12/11/2012
-15.4%
-11.8%
-10.1%
Despite Safety Concerns, Dynavax's Heplisav Should Receive FDA Approval DVAX Long
11/6/2012
-29.0%
-47.3%
-74.2%
Aegerion's Drug Lomitapide Should Receive FDA Approval AEGR Long
10/12/2012
73.2%
149.4%
413.6%